We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ViewRay Inc | NASDAQ:VRAY | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.025 | 0.027 | 0.0275 | 0 | 01:00:00 |
CUSIP No.
92672L107
|
|
1
|
NAME OF REPORTING
PERSONS
OrbiMed Advisors LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
o
(b)
o
|
||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
5,556,554 (1)
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
5,556,554 (1)
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,556,554 (1)
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.78% (2)
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IA
|
(1)
|
Includes (i) 5,149,019 outstanding shares of common stock, par value $0.01 per share (the “
Shares
”), of ViewRay, Inc., a Delaware corporation (the “
Issuer
”), and (ii) 407,535 Shares issuable upon the exercise of warrants to purchase shares (the “
Warrants
”).
|
(2)
|
This percentage is calculated based upon 95,730,214 Shares outstanding of the Issuer, as set forth in the Issuer’s
Form 10-Q
, filed with the Securities and Exchange Commission on November 9, 2018, and includes an additional 407,535 Shares subject to currently exercisable Warrants held by the Reporting Persons.
|
CUSIP No.
92672L107
|
|
1
|
NAME OF REPORTING
PERSONS
OrbiMed Capital GP III LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
o
(b)
o
|
||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
5,504,477 (1)
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
5,504,477 (1)
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,504,477 (1)
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.73% (2)
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
(1)
|
Includes (i) 5,100,785 outstanding shares of common stock, par value $0.01 per share (the “
Shares
”), of ViewRay, Inc., a Delaware corporation (the “
Issuer
”), and (ii) 403,692 Shares issuable upon the exercise of warrants to purchase shares (the “
Warrants
”).
|
(2)
|
This percentage is calculated based upon 95,730,214 Shares outstanding of the Issuer, as set forth in the Issuer’s
Form 10-Q
, filed with the Securities and Exchange Commission on November 9, 2018, and includes an additional 403,692 Shares subject to currently exercisable Warrants held by the Reporting Persons.
|
Item 1.
|
Security and Issuer
|
Item 2.
|
Identity and Background
|
(i)
|
name;
|
(ii)
|
business address;
|
(iii)
|
present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted;
|
(iv)
|
citizenship.
|
Item 3.
|
Source and Amount of Funds or Other Consideration
|
Item 4.
|
Purpose of Transaction
|
Item 5.
|
Interest in Securities of the Issuer
|
Seller
|
Date of Transaction
|
Transaction
|
Number of Shares
|
Price Per Share*
|
OPI III
|
September 14, 2018
|
Sold
|
133,795
|
$10.06
|
Associates III
|
September 14, 2018
|
Sold
|
1,274
|
$10.06
|
OPI III
|
October 3, 2018
|
Sold
|
245,363
|
$10.15
|
Associates III
|
October 3, 2018
|
Sold
|
2,337
|
$10.15
|
OPI III
|
October 17, 2018
|
Sold
|
236,210
|
$9.53
|
Associates III
|
October 17, 2018
|
Sold
|
2,490
|
$9.53
|
OPI III
|
October 18, 2018
|
Sold
|
15,190
|
$9.61
|
Associates III
|
October 18, 2018
|
Sold
|
158
|
$9.61
|
OPI III
|
October 19, 2018
|
Sold
|
84,115
|
$9.78
|
Associates III
|
October 19, 2018
|
Sold
|
885
|
$9.78
|
OPI III
|
November 6, 2018
|
Sold
|
495
|
$9.48
|
Associates III
|
November 6, 2018
|
Sold
|
5
|
$9.48
|
Item 6.
|
Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer
|
Item 7.
|
Materials to Be Filed as Exhibits
|
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, and OrbiMed Capital GP III LLC.
|
|
OrbiMed Advisors LLC
|
|
||
|
|
|
||
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
Name:
|
Jonathan T. Silverstein
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
OrbiMed Capital GP III LLC
|
|
||
|
|
|
|
|
|
By:
|
OrbiMed Advisors LLC
its Managing Member
|
||
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
Name:
|
Jonathan T. Silverstein
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
|
|
|
Name
|
Position with Reporting
Person
|
Principal Occupation
|
Carl L. Gordon
|
Member
|
Member
OrbiMed Advisors LLC
|
Sven H. Borho
German and Swedish Citizen
|
Member
|
Member
OrbiMed Advisors LLC
|
Jonathan T. Silverstein
|
Member
|
Member
OrbiMed Advisors LLC
|
W. Carter Neild
|
Member
|
Member
OrbiMed Advisors LLC
|
Geoffrey C. Hsu
|
Member
|
Member
OrbiMed Advisors LLC
|
Evan D. Sotiriou
|
Chief Financial Officer
|
Chief Financial Officer
OrbiMed Advisors LLC
|
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, and OrbiMed Capital GP III LLC.
|
1 Year ViewRay Chart |
1 Month ViewRay Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions